Organismal Biology, Ecology, and Evolution, The University of Montana. 32 Campus Drive, HS 104, Missoula, MT, 59801, USA; The Wildlife Biology Program, The University of Montana. 32 Campus Drive, HS 104, Missoula, MT, 59801, USA.
The Wildlife Biology Program, The University of Montana. 32 Campus Drive, HS 104, Missoula, MT, 59801, USA.
Mol Cell Endocrinol. 2020 Aug 20;514:110857. doi: 10.1016/j.mce.2020.110857. Epub 2020 May 11.
Glucocorticoids (GCs) circulate in the plasma bound to corticosteroid-binding globulin (CBG). Plasma CBG may limit access of glucocorticoids to tissues (acting as a sponge: the free hormone hypothesis), or may solely serve as a transport molecule, releasing GCs to tissues as the plasma moves through capillaries (the total hormone hypothesis). Both biomedical (focused on human health) and comparative (focused on ecological and evolutionary relevance) studies have worked to incorporate CBG in glucocorticoid physiology, and to understand whether free or total hormone is the biologically active plasma fraction. The biomedical field, however, has been well ahead of the comparative physiologists, and have produced results that can inform comparative research when considering the import of total vs. free plasma hormone. In fact, biomedical studies have made impressive strides regarding the function of CBG in tissues as well as plasma; we, however, focus solely on the plasma functions in this review as this is the primary area of disagreement amongst comparative physiologists. Here we present 5 sets of biomedical studies across genomics, pharmacology, cell culture, whole animal research, and human medicine that strongly support a role for CBG limiting hormone access to tissue. We also discuss three areas of concern across comparative researchers. In contrast to former publications, we are not suggesting that all comparative studies in glucocorticoid physiology must measure CBG, or that only free corticosterone levels are valid. However, we propose that comparative physiologists be aware of biomedical results as they investigate glucocorticoids and interpret how total hormone may or may not impact behavior and physiology of free-living vertebrates.
糖皮质激素(GCs)在血浆中与皮质类固醇结合球蛋白(CBG)结合循环。血浆 CBG 可能会限制糖皮质激素进入组织的能力(作为一种海绵:游离激素假说),或者仅作为一种运输分子,随着血浆穿过毛细血管,将 GCs 释放到组织中(总激素假说)。生物医学(关注人类健康)和比较生理学(关注生态和进化相关性)研究都致力于将 CBG 纳入糖皮质激素生理学,并了解游离或总激素是具有生物活性的血浆部分。然而,生物医学领域一直领先于比较生理学家,并取得了可以为比较研究提供信息的结果,当考虑总激素与游离激素对血浆的重要性时,这是比较生理学家关注的重点。事实上,生物医学研究在 CBG 在组织和血浆中的功能方面取得了令人瞩目的进展;然而,我们在本综述中仅关注血浆功能,因为这是比较生理学家之间主要的分歧点。在这里,我们提出了 5 组跨越基因组学、药理学、细胞培养、整体动物研究和人类医学的生物医学研究结果,这些研究结果强烈支持 CBG 限制激素进入组织的作用。我们还讨论了比较研究人员关注的三个问题。与以前的出版物不同,我们并不是建议所有关于糖皮质激素生理学的比较研究都必须测量 CBG,或者只有游离皮质酮水平是有效的。然而,我们建议比较生理学家在研究糖皮质激素并解释总激素如何可能或不可能影响自由生活的脊椎动物的行为和生理学时,了解生物医学的结果。